6 results  1 of 1 

1 Safety Results and Analysis of Eribulin Efficacy according to Previous Microtubules-Inhibitors Sensitivity in the French Prospective Expanded Access Program for Heavily Pre-treated Metastatic Breast Cancer
Renaud Sabatier, Véronique Diéras, Xavier Pivot, Etienne Brain, Henri Roché, Jean-Marc Extra, Audrey Monneur, Magali Provansal, Carole Tarpin, François Bertucci, Patrice Viens, Christophe Zemmour, Anthony Gonçalves
Cancer Res Treat.2018;50(4):1226-1237.   Published online 2017 December 28     DOI: http://dx.doi.org/10.4143/crt.2017.446
      
2 Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results
Yeon Hee Park, Tae Yong Kim, Young-Hyuck Im, Keun-Seok Lee, In Hae Park, Joohyuk Sohn, Soo-Hyeon Lee, Seock-Ah Im, Jee Hyun Kim, Se Hyun Kim, Soo Jung Lee, Su-Jin Koh, Ki Hyeong Lee, Yoon Ji Choi, Eun Kyung Cho, Suee Lee, Seok Yun Kang, Jae Hong Seo, Sung-Bae Kim, Kyung Hae Jung
Cancer Res Treat.2017;49(2):423-429.   Published online 2016 August 3     DOI: http://dx.doi.org/10.4143/crt.2016.191
      
3 Eribulin Mesylate Combined with Local Treatment for Brain Metastasis from Breast Cancer: Two Case Reports
Kyung-Do Byun, Sung Gwe Ahn, Hyung Joo Baik, Anbok Lee, Ki Beom Bae, Min Sung An, Kwang Hee Kim, Jae Ho Shin, Ha Kyoung Park, Heunglae Cho, Joon Jeong, Tae Hyun Kim
J Breast Cancer.2016;19(2):214-217.   Published online 2016 June 24     DOI: http://dx.doi.org/10.4048/jbc.2016.19.2.214
      
4 Patient Management with Eribulin in Metastatic Breast Cancer: A Clinical Practice Guide
Jungsil Ro, Fiona Tsui-Fen Cheng, Virote Sriuranpong, Antonio Villalon, B. K Smruti, Janice Tsang, Yoon Sim Yap,
J Breast Cancer.2016;19(1):8-17.   Published online 2016 March 25     DOI: http://dx.doi.org/10.4048/jbc.2016.19.1.8
      
5 Malignant Adenomyoepithelioma of the Breast and Responsiveness to Eribulin
Suee Lee, Sung Yong Oh, Sung-Hyun Kim, Ji Hyun Lee, Dae Cheul Kim, Se Heon Cho, Miri Lee, Hyo-Jin Kim
J Breast Cancer.2015;18(4):400-403.   Published online 2015 December 23     DOI: http://dx.doi.org/10.4048/jbc.2015.18.4.400
      
6 Eribulin for Advanced Breast Cancer: A Drug Evaluation
Alaaeldin Shablak
J Breast Cancer.2013;16(1):12-15.   Published online 2013 March 31     DOI: http://dx.doi.org/10.4048/jbc.2013.16.1.12
      

 1 of 1